s6y Altamira Therapeutics Ltd. 20-F

Altamira Therapeutics Ltd. 20-F, filed May 16, 2023: IDEA: XBRL DOCUMENT

Employee Benefits (Details) - Schedule of defined benefit cost and liability assumptions - CHF (SFr)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Schedule Of Defined Benefit Cost And Liability Assumptions Abstract      
Service cost SFr 256,336 SFr 159,085 SFr 151,624
Net interest expense 1,575 1,878 2,053
Administration expense 5,369 6,030 3,166
Total defined costs for the year recognized in profit or loss 263,280 166,993 156,843
Actuarial loss (gain) arising from changes in financial assumptions (876,841) (74,284) 13,031
Actuarial loss (gain) arising from experience adjustments (54,795) 463,238 45,881
Actuarial gain arising from demographic assumptions   (229,109)
Return on plan assets excluding interest income 490,359 (424,829) (32,794)
Total defined benefit cost for the year recognized in the other comprehensive loss (income) SFr 441,277 SFr (264,984) SFr 26,118
Discount rate 2.20% 0.30% 0.20%
Future salary increase 1.60% 0.85% 0.60%
Pension indexation 0.00% 0.00% 0.00%
Mortality and disability rates BVG2020 BVG2020 BVG2015G